Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400092628Phase 4Recruiting
Phase 4 trial of remimazolam and propofol (2 arms), sponsored by The First People's Hospital of Linping District, Hangzhou. Primary endpoints: Quality of Recovery-15 scale score and Inflammatory indicators. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400092628.